Abnormal endometrial development occurs during the luteal phase of nonsupplemented donor cycles treated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists.
Kolibianakis
Efstratios M
EM
Bourgain
Claire
C
Platteau
Peter
P
Albano
Carola
C
Van Steirteghem
Andre C
AC
Devroey
Paul
P
D000328:Adult; D004717:Endometrium / Q000166:cytology* / Q000187:drug effects*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000627:therapeutic use; D007987:Gonadotropin-Releasing Hormone / Q000037:antagonists & inhibitors / Q000627:therapeutic use; D006801:Humans; D008183:Luteal Phase; D008597:Menstrual Cycle / Q000187:drug effects; D008938:Mitosis / Q000187:drug effects; D009865:Oocytes; D010062:Ovulation Induction; D011994:Recombinant Proteins / Q000627:therapeutic use; D014019:Tissue Donors; D020858:Tissue and Organ Harvesting
D011994:Recombinant Proteins; D007987:Gonadotropin-Releasing Hormone; D005640:Follicle Stimulating Hormone